Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Recurrent B Acute Lymphoblastic Leukemia · Recurrent B-Cell Non-Hodgkin Lymphoma · Refractory B Acute Lymphoblastic Leukemia · Refractory B-Cell Non-Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
Contact: Study coordinator (Jennifer E. Agrusa) · jagrusa@med.umich.edu · 734-232-9335
Contact: Principal Investigator (Jennifer E. Agrusa)

Study leads

Jennifer E Agrusa, MD
Principal Investigator
University of Michigan Rogel Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Registry of Older Patients With Cancer

Chronic Myeloproliferative Disorders · Cognitive/Functional Effects · Leukemia

Abroad (travel likely)Recruiting

Boone, United States · Chapel Hill, United States

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Chronic Myeloproliferative Disorders · Leukemia · Lymphoma

Abroad (travel likely)Recruiting

Chapel Hill, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia · Refractory B Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States